Targeting proliferating tumor cells via the transcriptional control of therapeutic genes

Cancer Gene Therapy

Volumn 13, Issue 1, 2006, Pages 44-52

  Ho, I A W ^a   Hui, K M ^a   Lam, P Y P ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Apoptosis; Cell cycle regulatable; FADD; Fasl; HSV 1 amplicon viral vectors

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; HERPESVIRUS VECTOR; TRYPAN BLUE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CELL CYCLE G1 PHASE; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; GENETIC ENGINEERING; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; MITOSIS INHIBITION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; KIDNEY; MEMBRANE GLYCOPROTEINS; MICE; MODELS, GENETIC; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTORS;

ANIMALIA; HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 29144501203     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700864     Document Type: Article

References (18)

1. Ho IA, Hui KM, Lam P. Glioma-specific and cell cycle-regulated Herpes Simplex Virus Type 1 amplicon viral vector. Hum Gene Ther 2004; 15: 495-508.
2. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells 1994; 12: 440-455.
3. Rubinchik S, Wang D, Yu H, Fan F, Luo M, Norris J et al. A complex adenovirus vector that delivers FasL-GFP with combined prostate-specific and tetracycline-regulated expression. Mol Ther 2001; 4: 416-426.
4. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29-55.
5. Choi C, Benveniste EN. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 2004; 44: 65-81.
6. Weller M, Frei K, Groscurth P, Krammer P, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells, induction and modulation of sensitivity by cytokines. J Clin Invest 1994; 94: 954-964.
7. Weller M, Malipiero U, Rensing-Ehl A, Barr P, Fontana A. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 1995; 55: 2936-2944.
8. Karlsson T, Henriksson R, Hedman H. Induction of apoptosis in resistant glioma cells by synthetic caspase-activation. J Neuro-Oncol 2004; 66: 71-79.
9. Chinnaiyan A, O'Rourke K, Tewari M, Dixit V. FADD, a novel death domain-containing protein, interacts with the death domain of FAS and initiates apoptosis. Cell 1995; 81: 505-512.
10. Chinnaiyan A, Tepper C, Seldin M, O'Rourke K, Kischkel F, Hellbardt S et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996; 271: 4961-4965.
11. Grimm S, Stanger B, Leder P. RIP and FADD: two 'death domain' - containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci USA 1996; 93: 10923-10927.
12. Kondo S, Ishizaka Y, Okada T, Kondo Y, Hitomi M, Tanaka Y et al. FADD gene therapy for malignant gliomas in vitro and in vivo. Hum Gene Ther 1998; 9: 1599-1608.
13. Liu N, Lucibello FC, Korner K, Wolfraim LA, Zwicker J, Müller R. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res 1997; 25: 4915-4920.
14. Saeki Y, Breakefield XO, Chiocca EA. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA. Methods Mol Med 2003; 76: 51-60.
15. Olschowka JA, Bowers WJ, Hurley SD, Mastrangelo MA, Federoff HJ. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol Ther 2003; 7: 218-227.
16. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808-812.
17. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM. Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem 2004; 89: 168-178.
18. Schmidt F, Groscurth P, Kermer M, Dichgans J, Weller M. Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells. Acta Neuropathol. (Berlin) 2001; 101: 217-224.